Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program

Abstract

Background The Hospital Readmissions Reduction Program (HRRP) was introduced to reduce readmission rates among Medicare beneficiaries, however little is known about readmissions and costs for HRRP-targeted conditions in younger populations. The primary objective of this study was to examine readmission trends and costs for targeted conditions during policy implementation among younger and older adults in the U.S. Methods We analyzed the Nationwide Readmission Database from January 2010 to September 2015 in younger (18–64\u2009years) and older (≥65\u2009years) patients with acute myocardial infarction (AMI), heart failure (HF), pneumonia, and acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Pre- and post-HRRP periods were defined based on implementation of the policy for each condition. Readmission rates were evaluated using an interrupted time series with difference-in-difference analyses and hospital cost differences between early and late readmissions (≤30 vs. >\u200930\u2009days) were evaluated using generalized linear models. Results Overall, this study included 16,884,612 hospitalizations with 3,337,266 readmissions among all age groups and 5,977,177 hospitalizations with 1,104,940 readmissions in those aged 18–64\u2009years. Readmission rates decreased in all conditions. In the HRRP announcement period, readmissions declined significantly for those aged 40–64\u2009years for AMI ( p \u2009<\u20090.0001) and HF ( p \u2009=\u20090.003). Readmissions decreased significantly in the post-HRRP period for those aged 40–64\u2009years at a slower rate for AMI ( p \u2009=\u20090.003) and HF ( p \u2009=\u20090.05). Readmission rates among younger patients (18–64\u2009years) varied within all four targeted conditions in HRRP announcement and post-HRRP periods. Adjusted models showed a significantly higher readmission cost in those readmitted within 30\u2009days among younger and older populations for AMI ( p \u2009<\u20090.0001), HF ( p \u2009<\u20090.0001), pneumonia ( p \u2009<\u20090.0001), and AECOPD ( p \u2009<\u20090.0001). Conclusion Readmissions for targeted conditions decreased in the U.S. during the enactment of the HRRP policy and younger age groups (<\u200965\u2009years) not targeted by the policy saw a mixed effect. Healthcare expenditures in younger and older populations were significantly higher for early readmissions with all targeted conditions. Further research is necessary evaluating total healthcare utilization including emergency department visits, observation units, and hospital readmissions in order to better understand the extent of the HRRP on U.S. healthcare.